Warning: mkdir(): Permission denied in /home/virtual/lib/view_data.php on line 81
Warning: fopen(upload/ip_log/ip_log_2024-04.txt): failed to open stream: No such file or directory in /home/virtual/lib/view_data.php on line 83
Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 84 Serologic response to Pneumocystis carinii of Seoul National University Hospital patients
Serologic response to Pneumocystis carinii of Seoul National University Hospital patients
Sung-Tae Hong
Department of Parasitology and Institute of Endemic Diseases, Seoul National University College of Medicine, Seoul 110-460, Korea.
Abstract
A total of 2,580 sera of the patients who were consulted to the serology laboratory of the Seoul National University Hospital were collected in 1990. The sera were screened by micro-ELISA to detect IgG antibody reacting with Pneumocystis carinii antigen. The absorbances were 0.00 to 1.41 and mean 0.27 ± 0.253. As the positive criterion was set absorbance 0.2 or more with 70% sensitivity, total positive rate was 44.4%. Mean absorbances and positive rates were higher in children than in adults; 0.40 and 62.9% in 0 year group, 0.50 and 81.2% in 1 year group, 0.41 and 66.0% in 2-3 year group, 0.33 and 61.4% in 4-5 year group, 0.25 and 42.3% in 6-10 year group respectively. In the age groups over 11 years, the absorbances were in range of 0.16 to 0.23 and the positive rates were 26.1% to 41.5%. The present level of absorbances and positive rates could be regarded similar with those in normal Korean population. The present findings suggest that most humans are exposed to Pneumocystis within 2 years after birth and meet much less new antigenic challenge after 11 years in Korea.
Figures
Fig. 1 Absorbance at 490nm of the 10 positive reference sera by micro-ELISA.
Fig. 2 The positive rates(%) by micro-ELISA by the age groups.
Tables
Table 1 ELISA absorbance using Pneumocystis antigen in the subjected population by age and sex
References
1.
Blumenfeld W, Mandrell RE, Jarvis GA, Griffiss JM. Localization of host immunoglobulin G to the surface of Pneumocystis carinii. Infect Immun 1990;58(2):456–463.
2.
Burns SM, Read JA, Yap PL, Brettle RP. Reduced concentrations of IgG antibodies to Pneumocystis carinii in HIV-infected patients during active Pneumocystis carinii infection and the possibility of passive immunisation. J Infect 1990;20(1):33–39.
3.
Cheong SK, et al. J Korean Med Ass 1983;26(4):329–337.
4.
Cho SY, Hong ST, Rho YH, Choi SY, Han YC. Application of micro-ELISA in serodiagnosis of Human paragonimiasis. Korean J Parasitol 1981;19(2):151–156.
5.
Cushion MT. In vitro studies of Pneumocystis carinii. J Protozool 1989;36(1):45–52.
6.
Cushion MT, Ebbets D. Growth and metabolism of Pneumocystis carinii in axenic culture. J Clin Microbiol 1990;28(6):1385–1394.
7.
Cushion MT, Ruffolo JJ, Walzer PD. Analysis of the developmental stages of Pneumocystis carinii, in vitro. Lab Invest 1988;58(3):324–331.
8.
Edman JC, Kovacs JA, Masur H, Santi DV, Elwood HJ, Sogin ML. Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi. Nature 1988;334(6182):519–522.
9.
Frenkel JK, Bartlett MS, Smith JW. RNA homology and the reclassification of Pneumocystis. Diagn Microbiol Infect Dis 1990;13(1):1–2.
10.
Furuta T, et al. Jpn J Parasitol 1986;35(5):419–425.
11.
Graves DC. Immunological studies of Pneumocystis carinii. J Protozool 1989;36(1):60–69.
12.
Hong ST. Changes of anti-Clonorchis sinensis IgG antibody in serum after praziquantel treatment in human clonorchiasis. Korean J Parasitol 1988;26(1):1–8.
13.
Hong ST, Steele PE, Cushion MT, Walzer PD, Stringer SL, Stringer JR. Pneumocystis carinii karyotypes. J Clin Microbiol 1990;28(8):1785–1795.
14.
Kim CK, Foy JM, Cushion MT, Stanforth D, Linke MJ, Hendrix HL, Walzer PD. Comparison of histologic and quantitative techniques in evaluation of therapy for experimental Pneumocystis carinii pneumonia. Antimicrob Agents Chemother 1987;31(2):197–201.
15.
Maddison SE, Hayes GV, Slemenda SB, Norman LG, Ivey MH. Detection of specific antibody by enzyme-linked immunosorbent assay and antigenemia by counterimmunoelectrophoresis in humans infected with Pneumocystis carinii. J Clin Microbiol 1982;15(6):1036–1043.
16.
McLaren M, Draper CC, Roberts JM, Minter-Goedbloed E, Ligthart GS, Teesdale CH, Amin MA, Omer AH, Bartlett A, Voller A. Studies on the enzyme linked immunosorbent assay (ELISA) test for Schistosoma mansoni infections. Ann Trop Med Parasitol 1978;72(3):243–253.
17.
Meuwissen JH, Tauber I, Leeuwenberg AD, Beckers PJ, Sieben M. Parasitologic and serologic observations of infection with Pneumocystis in humans. J Infect Dis 1977;136(1):43–49.
18.
Peglow SL, Smulian AG, Linke MJ, Pogue CL, Nurre S, Crisler J, Phair J, Gold JW, Armstrong D, Walzer PD. Serologic responses to Pneumocystis carinii antigens in health and disease. J Infect Dis 1990;161(2):296–306.
19.
Pifer LL, Hughes WT, Stagno S, Woods D. Pneumocystis carinii infection: evidence for high prevalence in normal and immunosuppressed children. Pediatrics 1978;61(1):35–41.
20.
Sinclair K, Wakefield AE, Banerji S, Hopkin JM. Pneumocystis carinii organisms derived from rat and human hosts are genetically distinct. Mol Biochem Parasitol 1991;45(1):183–184.
21.
Stringer SL, Stringer JR, Blase MA, Walzer PD, Cushion MT. Pneumocystis carinii: sequence from ribosomal RNA implies a close relationship with fungi. Exp Parasitol 1989;68(4):450–461.
22.
Walzer PD, Stanforth D, Linke MJ, Cushion MT. Pneumocystis carinii: immunoblotting and immunofluorescent analyses of serum antibodies during experimental rat infection and recovery. Exp Parasitol 1987;63(3):319–328.
23.
Watanabe J, Hori H, Tanabe K, Nakamura Y. Phylogenetic association of Pneumocystis carinii with the 'Rhizopoda/Myxomycota/Zygomycota group' indicated by comparison of 5S ribosomal RNA sequences. Mol Biochem Parasitol 1989;32(2-3):163–167.
24.
Pifer LL, Niell HB, Langdon SB, Baltz S, Clark ST, Edwards CC, Woods DR. Evidence for depressed humoral immunity to Pneumocystis carinii in homosexual males, commercial plasma donors, and patients with acquired immunodeficiency syndrome. J Clin Microbiol 1987;25(6):991–995.
PDF Links
Full text via DOI
Download Citation 
